Literature DB >> 11965413

[Prevalence of epilepsy in Bakairi indians from Mato Grosso State, Brazil].

Moacir Alves Borges1, Edir Pina de Barros, Dirce Maria Trevisan Zanetta, Ana Paula Pina Borges.   

Abstract

The purpose of this cross-sectional study was to evaluate the prevalence of epilepsy in a population based sample: the Bakairi indians, who live on the banks of Paranatinga river in the central plateau of Mato Grosso state, Brazil. This population is composed of 483 inhabitants. The study was outlined in two stages, and the investigation was door-to-door in a total of 103 houses. The results of the instrument showed a sensitivity of 88% (CI- 95%, 84.9-93), specificity of 97.8% (CI-95, 95-98). The prevalence of active epilepsy was 12.4 per mil, and inactive was 6.2 per mil. This prevalence of the epilepsy was considered high probably due to some familial risk factor (p=0.04) among those Indians, while other factors were not important.

Entities:  

Mesh:

Year:  2002        PMID: 11965413     DOI: 10.1590/s0004-282x2002000100014

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  3 in total

Review 1.  Global disparities in the epilepsy treatment gap: a systematic review.

Authors:  Ana-Claire Meyer; Tarun Dua; Juliana Ma; Shekhar Saxena; Gretchen Birbeck
Journal:  Bull World Health Organ       Date:  2009-09-25       Impact factor: 9.408

2.  Epidemiologic Profile of Patients With Epilepsy in a Region of Southeast Brazil: Data From a Referral Center.

Authors:  Renata Parissi Buainain; Carlos Tadeu Parisi Oliveira; Fernando Augusto Lima Marson; Manoela Marques Ortega
Journal:  Front Neurol       Date:  2022-05-10       Impact factor: 4.086

Review 3.  Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis.

Authors:  Elisa Bruno; Alessandro Bartoloni; Lorenzo Zammarchi; Marianne Strohmeyer; Filippo Bartalesi; Javier A Bustos; Saul Santivañez; Héctor H García; Alessandra Nicoletti
Journal:  PLoS Negl Trop Dis       Date:  2013-10-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.